Medclair - breakthrough in the UK market
Medclair, the specialists in safe nitrous oxide management, has been commissioned to deliver two test installations for the destruction of nitrous oxide to two hospitals in Manchester, United Kingdom.
The UK is a very important market for Medclair as nitrous oxide is used in the majority of all births. The country has historically not dealt with the problem of nitrous oxide, but recently the country has launched a major project aimed at reducing greenhouse gas emissions in the healthcare sector.
It is already known that nitrous oxide is a work environment concern, however, in some cases this has been overlooked or the problem handled by venting the gas out of the treatment rooms. This is of course an unfortunate solution as one does not have control over any contamination of personnel but mainly a very large environmental problem given the fact that 1 kg of nitrous oxide corresponds to 297 kg of CO2 in negative environmental impact.
The agreement with the hospital means that Medclair delivers 2 mobile destroyers to be used by staff from several clinics in the north-west of England. The purpose is to learn more about safe nitrous oxide management under Medclair's guidance and to adapt treatments so that the gas can be efficiently collected and destroyed in a future large-scale investment.
"It is very gratifying that we now gained the trust to help the English healthcare system take the step to a safe nitrous oxide treatments. We have long relationships with people in the healthcare sector in UK and this agreement means that we now have a foothold in the British Isles. UK have a very high use of nitrous oxide but has so far handled the gas in a way that would be unacceptable in Sweden and other places. We are pleased that the debate in England now sheds light on the sector where we can contribute. also satisfactory to be able to actively contribute to reducing the climate problem." says Mikael König, President and CEO
For further information please contact:
Mikael König, CEO, Spintso International AB (publ), Tel: 070-486 17 98, e-mail: mikael.konig@medclair.se
